These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 12623829

  • 21. Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required?
    Warkentin TE, Greinacher A, Koster A.
    Ann Thorac Surg; 2009 May; 87(5):1633-40. PubMed ID: 19379937
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Heparin-induced thrombocytopenia.
    Chong BH, Chong JJ.
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):547-59. PubMed ID: 15225114
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Usefulness of optical density values from heparin-platelet factor 4 antibody testing and probability scoring models to diagnose heparin-induced thrombocytopenia.
    Janatpour KA, Gosselin RC, Dager WE, Lee A, Owings JT, Zhou J, Wun T.
    Am J Clin Pathol; 2007 Mar; 127(3):429-33. PubMed ID: 17276943
    [Abstract] [Full Text] [Related]

  • 27. Deep venous thrombosis, myocardial infarction, and occlusion of vascular access associated with heparin-induced thrombocytopenia in a diabetic hemodialysis patient.
    Igaki N, Matsuda T, Yatani H, Kawaguchi T, Kida A, Yanase K, Moriguchi R, Sakai M, Tamada F, Goto T.
    Clin Exp Nephrol; 2003 Dec; 7(4):306-10. PubMed ID: 14712362
    [Abstract] [Full Text] [Related]

  • 28. Report of a patient with heparin-induced thrombocytopenia type II associated with IgA antibodies only.
    Meyer O, Aslan T, Koster A, Kiesewetter H, Salama A.
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):373-5. PubMed ID: 16959694
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Central retinal vein occlusion with further reduction of retinal blood flow one year after radial optic neurotomy.
    Horio N, Horiguchi M.
    Am J Ophthalmol; 2005 May; 139(5):926-7. PubMed ID: 15860308
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Frequency of anti-heparin-PF4 complex antibodies (HIT antibodies) in uremic patients on chronic intermittent hemodialysis.
    Matsuo T, Kobayashi H, Matsuo M, Wanaka K, Nakamoto H, Matsushima H, Sakai R.
    Pathophysiol Haemost Thromb; 2006 May; 35(6):445-50. PubMed ID: 17565238
    [Abstract] [Full Text] [Related]

  • 34. The approach to heparin-induced thrombocytopenia.
    Linkins LA, Warkentin TE.
    Semin Respir Crit Care Med; 2008 Feb; 29(1):66-74. PubMed ID: 18302088
    [Abstract] [Full Text] [Related]

  • 35. [Heparin-induced thrombocytopenia in hemodialysis. Case report and review of the literature].
    Henríquez F, Rodríguez A, Mora C, Sánchez-Deig E, Macía M, Navarro J.
    Nefrologia; 2006 Feb; 26(6):734-7. PubMed ID: 17227252
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study.
    Gettings EM, Brush KA, Van Cott EM, Hurford WE.
    Crit Care; 2006 Feb; 10(6):R161. PubMed ID: 17109753
    [Abstract] [Full Text] [Related]

  • 40. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
    Everett BM, Yeh R, Foo SY, Criss D, Van Cott EM, Laposata M, Avery EG, Hoffman WD, Walker J, Torchiana D, Jang IK.
    Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.